HRC image

MRI machine in bright pink light

The HRC in Cardiovascular and respiratory medicine drives innovation and supports the development of HealthTech solutions to address the unmet needs outlined in the NHS Long Term Plan. The team aims to catalyse innovation in HealthTech for the diagnosis and management of cardiovascular and respiratory diseases through cutting-edge technologies and digitally enabled care. This empowers patients and their caregivers to effectively manage cardiovascular health and conditions. They bring together their vast clinical expertise to support researchers and industry throughout the UK to enhance clinical service quality and reduce variation in patient care.

About HRC's theme

Cardiovascular disease (CVD) and respiratory medicine is a combined medical specialty that integrates cardiology and pulmonology to treat conditions of the heart and circulatory systems, and the lungs and respiratory systems. It focuses on diagnosing, treating, and managing diseases of the heart, blood vessels, and lungs, and includes conditions like coronary heart disease and heart failure, high blood pressure, asthma, and chronic obstructive pulmonary disease (COPD).

Support provided

  • Advanced physiological biomarkers for home monitoring in chronic obstructive pulmonary disease (COPD).
  • AI-based CT lung vasculature imaging for disease prognostication and progression in pulmonary thromboembolism / pulmonary hypertension subclasses.
  • App-based technologies and implantable pulmonary artery pressure monitors for home exercise testing, activity monitoring and drug titration in patients with pulmonary hypertension.
  • Physiology-based technical engineering in devices to improve long-term outcome in sleep-disordered breathing and chronic respiratory failure.
  • Leverage local expertise for the technology evaluation of novel digital health solutions in collaboration with clinicians and methodologists.
  • Promote the creation of well-curated clinical databases, to accelerate evaluation of novel technologies.
  • Reduce inequalities and involve the public, patients and carers ensuring our research has clinical impact and empower patients and their caregivers to effectively manage cardiovascular health and conditions.
  • Catalyse innovation in HealthTech for the diagnosis and management of cardiovascular and respiratory diseases through cutting-edge technologies and digitally enabled care.
  • Understand the needs of those affected by children's heart disease and develop healthtech that supports the broader wellbeing of young people, and expose the cost of caring for children with heart disease.
  • Health technology evaluations - Supporting, piloting or co-developing novel HealthTech in key areas of unmet need.
  • Access to key opinion leaders, researchers and clinical and scientific experts in areas relating to cardiovascular and respiratory medicine.
  • Optimise the pipeline by coordinating resources while building capacity through short practical courses in health technology assessment, trial statistics, and health economics for NHS professionals at all career stages.
  • Access to key opinion leaders, researchers and clinical and scientific experts in areas relating to cardiovascular and respiratory medicine.

  • Advanced respiratory monitoring, imaging and treatment
  • Cardiovascular disease in adults
  • Cardiovascular interventions
  • Heart disease in children 
  • Medical device evaluation (adaptable to all TRLs) 
  • Process evaluation
  • Evidence generation for developers, adopters, decision makers
  • Health technology assessment
  • Human factors, heuristics and usability
  • Mixed qualitative and quantitative methods
  • Co-design of devices and adoption
  • Pre-implementation support
  • Contextual analysis
  • "Living Lab" services (human factors techniques)
  • Health economics and Health Tech Assessment (HTA)
  • Human factors analysis and usabilty assessment (instrumented and heuristic)
  • Codesign
  • Unmet needs gathering and assessment through patient and public involvement
  • Cardiology
  • Respiratory medicine
  • Regulatory advice
  • Vascular surgery
  • Biomedical engineering
  • Quality management systems
  • Clinical trials, first in man
  • System design
  • Technology adoption
  • Post-market surveillance and real-world evidence

  • Med Accelerator program targeted at early-stage ideas, providing training and support for collaborative grant applications
  • Venture Builder program that assists semi-developed products to achieve CE marking through the King's Technology Evaluation Centre (KiTEC)
  • Manfacture of Active Implants & Surgical Instruments (MAISI)
  • London Institute for Healthcare Engineering (LIHE)
  • SIE Ventures
  • Heart, Lung & Critical Care (HLCC) clinical group
  • CARDIAC MRI
  • Access to ethically approved research databases and tissue banks